(Press-News.org) Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, account for nearly 7 percent of medication errors in hospitalized patients.
With health care organizations facing greater pressure to ensure the safe and effective use of anticoagulants, new guidelines have been developed by a panel of health care experts led by Edith Nutescu, clinical pharmacy professor at the University of Illinois at Chicago and director of UIC's Antithrombosis Center, and endorsed by the board of directors of the Anticoagulation Forum, a group dedicated to optimizing anticoagulation care.
The eight procedures have been published in the Annals of Pharmacotherapy.
Standardized dosing protocols should be available on each hospital floor or be accessible through the hospital's electronic medical record or intranet site. Technology – computerized physician order entry, bar code scanning, programmable infusion pumps, and examining a patient's range of dosage – can also be used in reducing medication errors. In the absence of technology-based systems, having a pharmacist on patient rounds has been shown to reduce errors by up to 78 percent, Nutescu said.
A multidisciplinary team comprised of physicians, nurses, and pharmacists should care for each patient. Clinicians in quality and safety, laboratory, dietary, and information technology should also be considered for the team. A team leader will provide better communication about the anticoagulation management system to team members, or other specialized practitioners, should complex therapeutic situations arise.
The anticoagulation management system must incorporate a reliable means (electronic whenever possible) of identifying and tracking patients receiving therapy. It should be integrated with all patient-care resources in the health care system to ensure accurate and efficient communication of patient information and optimal care.
Evidence-based standards of practice should be used to ensure the appropriate management of all drug therapies. The clinical use of all treatments should be organized on a drug-specific basis using protocols, guidelines, policies and procedures, Nutescu said. Clinical standards should be periodically reviewed and updated to ensure they reflect current evidence and are coordinated with other policies and procedures.
Inadequate knowledge of a patient's medication or condition is one of the most frequently cited causes of medication prescribing errors, said Nutescu. Therefore, the anticoagulation management system should provide staff training, ongoing educational development and documented competency assessment for all multidisciplinary personnel involved in the therapy.
To achieve better patient outcomes, patient education is vital. "Many patients have inadequate knowledge regarding their medication therapy," Nutescu said. "Improved outcomes have been reported when patients take responsibility for, understand, and adhere to an anticoagulation plan of care." Patient education may include face-to-face interaction, group training sessions, and written and audiovisual materials. Written materials should be developed at an appropriate reading level and, when possible, in the patient's native language.
Procedures should be designed for patients' safe transition from inpatient to outpatient, or to other settings. Patients with complex or chronic medical conditions, including those on high-risk anticoagulation therapy, are prone to adverse outcomes from inadequate care transitions, Nutescu said. Three elements of effective care transitions include: education on blood thinning agents; timely follow-up care with the primary care physician or specialist; and communication between patient and health care provider.
Continuous quality improvement is essential to improving patient safety and optimizing outcomes while reducing costs, Nutescu said. Reviewing how well the system works and what impact it ultimately has on the patient are two components that should be employed to show how quality is being improved.
###
Nutescu was assisted by Ann Wittkowsky, University of Washingtion, Seattle; Allison Burnett, University of New Mexico Health Sciences Center, Albuquerque; Dr. Geno Merli, Thomas Jefferson University Hospital, Philadelphia; Dr. Jack Ansell, Lenox Hill Hospital, New York; and Dr. David Garcia, University of Washington, Seattle.
New blood-thinner measures may cut medication errors
2013-05-22
ELSE PRESS RELEASES FROM THIS DATE:
Study shows low rate of late lumen loss with bioresorbable DESolve device
2013-05-22
21 May 2013, Paris, France: The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today.
DESolve (Elixir Medical Corporation) is the first bioresorbable PLLA-based polymer scaffold that releases novolimus, a major metabolite of sirolimus. "The degradation time is about one year," explained the lead study author Alexandre Abizaid, Director of Interventional Cardiology at Institute ...
Whirlpools on the nanoscale could multiply magnetic memory
2013-05-22
"We spent 15 percent of home energy on gadgets in 2009, and we're buying more gadgets all the time," says Peter Fischer of the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab). Fischer lets you know right away that while it's scientific curiosity that inspires his research at the Lab's Advanced Light Source (ALS), he intends it to help solve pressing problems.
"What we're working on now could make these gadgets perform hundreds of times better and also be a hundred times more energy efficient," says Fischer, a staff scientist in the Materials ...
UCLA life scientists present new insights on climate change and species interactions
2013-05-22
UCLA life scientists provide important new details on how climate change will affect interactions between species in research published online May 21 in the Journal of Animal Ecology. This knowledge, they say, is critical to making accurate predictions and informing policymakers of how species are likely to be impacted by rising temperatures.
"There is a growing recognition among biologists that climate change is affecting how species interact with one another, and that this is going to have very important consequences for the stability and functioning of ecosystems," ...
UCI chemists devise inexpensive, accurate way to detect prostate cancer
2013-05-22
Irvine, Calif., May 22, 2013 – Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published today in the Journal of the American Chemical Society.
After more than a decade of work, UC Irvine chemists have created a way to clearly identify clinically usable markers for prostate cancer in urine, meaning that the disease could be detected far sooner, with greater accuracy and at dramatically lower cost. The same technology could potentially be used for bladder and multiple myeloma cancers, ...
Study finds COPD is over-diagnosed among uninsured patients
2013-05-22
ATS 2013, PHILADELPHIA ─More than 40 percent of patients being treated for COPD at a federally funded clinic did not have the disease, researchers found after evaluating the patients with spirometry, the diagnostic "gold standard" for chronic obstructive pulmonary disease.
"While there have been many studies of the under-diagnosis of COPD, there has not been a U.S.-based study that has quantified the problem of over-diagnosis," said Christian Ghattas, MD., MSc, a second-year medical resident at Saint Elizabeth Health Center in Youngstown, Ohio, who will present ...
Scientists uncover molecular roots of cocaine addiction in the brain
2013-05-22
Researchers at Johns Hopkins have unraveled the molecular foundations of cocaine's effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already proven safe for humans, is undergoing further animal testing in preparation for possible clinical trials in cocaine addicts, the researchers say.
"It was remarkably serendipitous that when we learned which brain pathway cocaine acts on, we already knew of a compound, CGP3466B, that blocks that specific pathway," says Solomon Snyder, M.D., a professor of neuroscience ...
Addiction to unhealthy foods could help explain the global obesity epidemic
2013-05-22
Toronto, May 22 2013 - Research presented today shows that high-fructose corn syrup can cause behavioural reactions in rats similar to those produced by drugs of abuse such as cocaine. These results, presented by addiction expert Francesco Leri, Associate Professor of Neuroscience and Applied Cognitive Science at the University of Guelph, suggest food addiction could explain, at least partly, the current global obesity epidemic. These results were presented at the 2013 Canadian Neuroscience Meeting, the annual meeting of the Canadian Association for Neuroscience - Association ...
Addiction as a disorder of decision-making
2013-05-22
Toronto - May 22 2013: New research shows that craving drugs such as nicotine can be visualized in specific regions of the brain that are implicated in determining the value of actions, in planning actions and in motivation. Dr. Alain Dagher, from McGill University, suggests abnormal interactions between these decision-making brain regions could underlie addiction. These results were presented at the 2013 Canadian Neuroscience Meeting, the annual meeting of the Canadian Association for Neuroscience - Association Canadienne des Neurosciences (CAN-ACN).
Neuroeconomics is ...
How healthy are you for your age?
2013-05-22
VIDEO:
The video as it appears on JoVE.com.
Click here for more information.
On May 22, JoVE will publish details of a technique to measure the health of human genetic material in relation to a patient’s age. The method is demonstrated by the laboratory of Dr. Gil Atzmon at New York’s Albert Einstein College of Medicine. Dr. Atzmon hopes that the dissemination of this technique will lead to the development of a “genetic thermometer” to assess a patient’s health in relation to ...
Costs to treat stroke in America may double by 2030
2013-05-22
Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.
In a statement published in Stroke, an American Heart Association journal, the association cites the aging U.S. population as the main reason for the increases and predicts that by 2030:
Almost 4 percent of U.S. adults — nearly one in 25 — will have a stroke. This translates into an additional 3.4 million people with stroke in 2030.
Costs to treat stroke may increase ...